Bluejay diagnostics provides second quarter business and corporate update

Acton, mass., aug. 07, 2025 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended june 30, 2025, and provided an update on its symphony il-6 test program and key operational milestones.
BJDX Ratings Summary
BJDX Quant Ranking